Literature DB >> 7261285

Myocardial infarct size and location in relation to the coronary vascular bed at risk in man.

J T Lee, R E Ideker, K A Reimer.   

Abstract

Recent infarcts were compared with the anatomic boundaries of the involved vascular bed in human hearts to determine the amount and location of necrosis in relation to the myocardium at risk. The coronary arteries were injected with BaSO4 in 18 human hearts with 3-16-day-old infarcts. Thin (3-4 mm) slices were cut at 10-15 mm intervals, photographed, x-rayed and used for histologic analysis. Infarct outlines were traced from gross photographs using histologic confirmation of infarct boundaries, and the vascular bed was independently traced from the x-rays. Ischemic bed size and infarct size were then calculated by computerized planimetry. Infarct size ranged from 13-72% of the left ventricle (mean 30 +/- 3.6%) and was linearly related to the size of the occluded vascular bed (r = 0.93). However, the infarcts were always smaller than the occluded beds. They involved 50-88% of the ischemic bed (mean 69 +/- 3.0%) due to variation in the transmural extent of necrosis. A lateral zone of viable muscle within the ischemic bed was present but was consistently narrow (mean 1.7 +/- 0.3 mm) so that the infarcts involved 93 +/- 2.3% of the width of the bed at risk. Thus, ischemic bed size is a major determinant of infarct size in fatal human infarcts. When natural limitation of infarct size occurs, it is due primarily to limitation of the transmural extent of necrosis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7261285     DOI: 10.1161/01.cir.64.3.526

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  The direct incorporation of perfusion defect information to define ischemia and infarction in a finite element model of the left ventricle.

Authors:  Alexander I Veress; George S K Fung; Taek-Soo Lee; Benjamin M W Tsui; Gregory A Kicska; W Paul Segars; Grant T Gullberg
Journal:  J Biomech Eng       Date:  2015-02-25       Impact factor: 2.097

2.  Diagnostic performance of the quantification of myocardium at risk from MPI SPECT/CTA 2G fusion for detecting obstructive coronary disease: A multicenter trial.

Authors:  Marina Piccinelli; Cesar Santana; Gopi Kiran R Sirineni; Russell D Folks; C David Cooke; Chesnal D Arepalli; Santiago Aguade-Bruix; Zohar Keidar; Alex Frenkel; Ora Israel; Jaume Candell-Riera; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2017-02-13       Impact factor: 5.952

3.  The assessment of ischaemic burden: validation of a functional jeopardy score against cardiovascular magnetic resonance perfusion imaging.

Authors:  Shazia T Hussain; Geraint Morton; Kalpa De Silva; Roy Jogiya; Andreas Schuster; Matthias Paul; Divaka Perera; Eike Nagel
Journal:  Clin Res Cardiol       Date:  2016-10-20       Impact factor: 5.460

4.  Angiographic validation of magnetic resonance assessment of myocardium at risk in non-ST-elevation myocardial infarction.

Authors:  Dominik Buckert; Manuela Mariyadas; Thomas Walcher; Volker Rasche; Jochen Wöhrle; Wolfgang Rottbauer; Peter Bernhardt
Journal:  Int J Cardiovasc Imaging       Date:  2013-04-02       Impact factor: 2.357

5.  Treatment of acute myocardial ischemia.

Authors:  R B Jennings
Journal:  West J Med       Date:  1987-07

6.  T2-weighted imaging to assess post-infarct myocardium at risk.

Authors:  Matthias G Friedrich; Han W Kim; Raymond J Kim
Journal:  JACC Cardiovasc Imaging       Date:  2011-09

7.  Quantification of myocardial area at risk in the absence of collateral flow: the validation of angiographic scores by myocardial perfusion single-photon emission computed tomography.

Authors:  José F Rodríguez-Palomares; Albert Alonso; Gerard Martí; Santiago Aguadé-Bruix; M T González-Alujas; Guillermo Romero-Farina; Jaume Candell-Riera; Bruno García del Blanco; Artur Evangelista; David García-Dorado
Journal:  J Nucl Cardiol       Date:  2012-11-10       Impact factor: 5.952

8.  Effect of early treatment with propranolol on left ventricular function four weeks after myocardial infarction.

Authors:  M A Brown; R M Norris; P F Barnaby; G G Geary; P W Brandt
Journal:  Br Heart J       Date:  1985-10

Review 9.  Assessment of residual viability in patients with myocardial infarction using magnetic resonance techniques.

Authors:  U Sechtem; E Voth; F Baer; C Schneider; P Theissen; H Schicha
Journal:  Int J Card Imaging       Date:  1993

10.  Relations between collateral flow and tissue salvage in the risk area after acute coronary occlusion in dogs: a topographical analysis.

Authors:  Y Maruoka; H Tomoike; Y Kawachi; K Noguchi; M Nakamura
Journal:  Br J Exp Pathol       Date:  1986-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.